These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7557496

  • 21. Natural killer cell levels in older adult mice are gender-dependent: thyroxin is a gender-independent natural killer cell stimulant.
    Mahoney MX, Currier NL, Miller SC.
    Nat Immun; 1998; 16(4):165-74. PubMed ID: 10366787
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of recombinant human macrophage colony-stimulating factor in combination with whole-body hyperthermia in the treatment of mice infected with the polycythemia-inducing strain of the Friend virus complex.
    Lu L, Shen RN, Zhou SZ, Wu B, Kim YJ, Lin ZH, Ruscetti S, Ralph P, Broxmeyer HE.
    Exp Hematol; 1991 Sep; 19(8):804-9. PubMed ID: 1907925
    [Abstract] [Full Text] [Related]

  • 23. [Studies on the possible causes of decreasing NK cell activity in tumor-bearing mice. I. The number of NK cells in the spleens of tumor-bearing mice is higher than that in normal mice].
    Fu JY.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Dec; 11(6):421-4. PubMed ID: 2534577
    [Abstract] [Full Text] [Related]

  • 24. In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states.
    Butler LD, Browne CP, Layman NK, Riedl P, Tang J, Marder P, DeLong D, Manetta J, Bobbitt L, Strnad J.
    Cancer Res; 1988 Nov 01; 48(21):6081-9. PubMed ID: 3048654
    [Abstract] [Full Text] [Related]

  • 25. Soluble glucan and lymphokine-activated killer (LAK) cells in the therapy of experimental hepatic metastases.
    Sherwood ER, Williams DL, McNamee RB, Jones EL, Browder IW, Di Luzio NR.
    J Biol Response Mod; 1988 Apr 01; 7(2):185-98. PubMed ID: 3283299
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic efficacy of human recombinant interleukin-2 (TGP-3) alone or in combination with cyclophosphamide and immunocompetent cells in allogeneic, semi-syngeneic, and syngeneic murine tumors.
    Ootsu K, Gotoh K, Houkan T.
    Cancer Immunol Immunother; 1989 Apr 01; 30(2):71-80. PubMed ID: 2598180
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. CVT-E002 stimulates the immune system and extends the life span of mice bearing a tumor of viral origin.
    Miller SC, Delorme D, Shan JJ.
    J Soc Integr Oncol; 2009 Apr 01; 7(4):127-36. PubMed ID: 19883528
    [Abstract] [Full Text] [Related]

  • 31. TNF-alpha further augments natural killer cells when co-administered with an interferon inducer to irradiated, leukemic, bone-marrow-transplanted mice.
    Currier NL, Miller SC.
    Cancer Chemother Pharmacol; 2001 Apr 01; 47(2):185-6. PubMed ID: 11269746
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
    Thompson JA, Peace DJ, Klarnet JP, Kern DE, Greenberg PD, Cheever MA.
    J Immunol; 1986 Dec 01; 137(11):3675-80. PubMed ID: 3491145
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer.
    Wiltrout RH, Boyd MR, Back TC, Salup RR, Arthur JA, Hornung RL.
    J Immunol; 1988 May 01; 140(9):3261-5. PubMed ID: 3258894
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of histamine type-2 receptor antagonists on indomethacin and IL-2 immunotherapy of metastasis.
    Saarloos MN, Khoo NK, Lala PK.
    Clin Exp Metastasis; 1993 May 01; 11(3):275-83. PubMed ID: 8097142
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.